These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 23128439

  • 1. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
    Consoli D, Bosco D, Postorino P, Galati F, Plastino M, Perticoni GF, Ottonello GA, Passarella B, Ricci S, Neri G, Toni D, EPIC Study.
    Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
    [Abstract] [Full Text] [Related]

  • 2. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.
    Helmstaedter C, Witt JA.
    Epilepsy Behav; 2010 May; 18(1-2):74-80. PubMed ID: 20462801
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G, Gomceli YB, Unal Y, Inan LE.
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [Abstract] [Full Text] [Related]

  • 4. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C, Ishihara K, Nagayama T, Serikawa T, Sasa M.
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [Abstract] [Full Text] [Related]

  • 5. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).
    Stepanova D, Beran RG.
    Seizure; 2014 May; 23(5):371-6. PubMed ID: 24630809
    [Abstract] [Full Text] [Related]

  • 6. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B, KOMET Study Group.
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [Abstract] [Full Text] [Related]

  • 7. Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure.
    Gilad R, Sadeh M, Rapoport A, Dabby R, Boaz M, Lampl Y.
    Clin Neuropharmacol; 2007 Oct; 30(4):189-95. PubMed ID: 17762314
    [Abstract] [Full Text] [Related]

  • 8. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B, Marson AG, Noack-Rink M, Ramirez F, Tofighy A, Werhahn KJ, Wild I, Trinka E.
    BMC Neurol; 2016 Aug 23; 16(1):149. PubMed ID: 27552848
    [Abstract] [Full Text] [Related]

  • 9. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL, Wang YY, Cook MJ, Murphy MA, D'Souza WJ.
    Epilepsia; 2013 Jan 23; 54(1):45-57. PubMed ID: 22738092
    [Abstract] [Full Text] [Related]

  • 10. Use of levetiracetam in hospitalized patients.
    Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, Maestro I.
    Epilepsia; 2006 Dec 23; 47(12):2186-8. PubMed ID: 17201722
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N, Jones J, Tonner F.
    Epilepsia; 2012 Jan 23; 53(1):111-9. PubMed ID: 22050371
    [Abstract] [Full Text] [Related]

  • 12. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam.
    Meador KJ, Gevins A, Loring DW, McEvoy LK, Ray PG, Smith ME, Motamedi GK, Evans BM, Baum C.
    Neurology; 2007 Nov 27; 69(22):2076-84. PubMed ID: 18040014
    [Abstract] [Full Text] [Related]

  • 13. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y, Altun Y, Ekmekci K, Ozkul Y.
    Clin Neuropharmacol; 2013 Nov 27; 36(2):55-8. PubMed ID: 23503548
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam: safety and efficacy in neonatal seizures.
    Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J.
    Eur J Paediatr Neurol; 2011 Jan 27; 15(1):1-7. PubMed ID: 21094062
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of anti-epileptic drugs-an internet study.
    Wieshmann UC, Baker G.
    Acta Neurol Scand; 2017 May 27; 135(5):533-539. PubMed ID: 27757951
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z, Li JM, Wang XF, Xiao F, Xi ZQ, Lv Y, Sun HB.
    Eur Neurol; 2009 May 27; 61(4):233-9. PubMed ID: 19176965
    [Abstract] [Full Text] [Related]

  • 17. Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study.
    Belcastro V, Costa C, Galletti F, Autuori A, Pierguidi L, Pisani F, Calabresi P, Parnetti L.
    Epilepsy Res; 2008 Dec 27; 82(2-3):223-6. PubMed ID: 18829259
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H, Daniluk J, Lotay N, DeRossett S, Edwards S, Brandt C.
    Seizure; 2015 Aug 27; 30():93-100. PubMed ID: 26216692
    [Abstract] [Full Text] [Related]

  • 19. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar 27; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 20. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar 27; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.